Pharmafile Logo
Pharmafocus logo
Advanced Search

pharma

Showing 15 posts of 2914 posts found.

What might the NHS white paper mean for Pharma commercial models?

July 16, 2010
Sales and Marketing Kinapse, NHS, White paper, commercial model, life sciences, pharma

Earlier this year we published a white paper on the new commercial realities and their implications for Life Sciences companies.

Feature
Thought Leadership
George Osborne

Mixed reaction for Osborne’s first Budget

June 23, 2010
Research and Development, Sales and Marketing biotech, pharma, tax, tax relief

George Osborne’s first Budget as chancellor has had a mixed reception from the pharma and biotech sectors. The BioIndustry Association …

News

Doctors shunning pharma rep visits

May 11, 2010
pharma, sales force, sales force effectiveness, sales representatives

More and more doctors in the US are refusing to see pharma companies’ sales representatives, according to new research. The …

News

Indian pharma meets Big pharma

June 17, 2009
Research and Development, Sales and Marketing India, business models, clinical trials, pharma

 

Feature

Biotech partnering in the credit crunch

May 1, 2009
Research and Development biotech, partnering, pharma

Action Pharma’s Torben Jung Laursen explores the new challenges facing pharma-biotech partnering as a result of the economic downturn.In today’s …

Feature

2-in-1: Merck and Schering-Plough

April 8, 2009
Research and Development, Sales and Marketing Merck, Schering-Plough, merger, pharma

The Merck and Schering-Plough merger creates a new industry giant to challenge Pfizer in terms of its scale and annual …

Feature

Grand Designs

March 25, 2009
Sales and Marketing NHS, healthcare, outcomes, patient, pharma

Feature

What are pharma’s core competencies?

February 5, 2009
Research and Development, Sales and Marketing pharma, strategy

Pharma has always been a highly profitable industry, and has historically been among the best performing industrial sectors in terms …

Feature

UK Biotech: time for bold and affirmative action

January 22, 2009
Research and Development, Sales and Marketing BTG, Chris Collins, Christopher Evans, Neuropharm, Plethora, UK, biotech, pharma, strategy

Biotech leaders in the UK say the cash-stricken industry has reached ‘breaking point’, and have made an unprecedented plea for …

Feature

A postcard from … Spain

January 14, 2009
Research and Development, Sales and Marketing Spain, healthcare, pharma

Feature

NHS 2008: Rejuvenating the 60 year-old service

December 31, 2008
Sales and Marketing NHS, collaborations, healthcare, industry relations, pharma

  A review of the NHS in 2008 NHS-pharma collaborations come of ageIn January, new guidelines were agreed to help NHS …

Feature

2008: A year in the life of UK pharma

December 31, 2008
Research and Development, Sales and Marketing 2008, YIR, patients, pharma, review, social networking, year in review

  Patient power proves decisive in battle for accessSocial networking helped a new breed of informed patient advocates win the …

Feature

Key expert-pharma relations: a new era

October 20, 2008
Medical Communications, Sales and Marketing industry relations, key opinion leaders, pharma

The relationship between doctors and the pharmaceutical industry has attracted considerable criticism in the past five years. Scepticism has risen, …

Feature

Living with the Code of Practice

September 4, 2008
Medical Communications, Sales and Marketing ABPI, UK, code, marketing, pharma

The 2008 edition of the ABPI Code of Practice came into force on 1 July and the industry is fairly …

Feature

Pharma-Patient group relationships

July 24, 2008
Research and Development, Sales and Marketing industry relations, patient groups, pharma

In the headlong race for global domination, pharma companies are in the process of flattening their hierarchies, slashing bureaucracy, streamlining …

Feature
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026